Abstract
Aims/hypothesis
Iron accumulation affects obesity and diabetes, both of which are ameliorated by iron reduction. Ferritin, an iron-storage protein, plays a crucial role in iron metabolism. H-ferritin exerts its cytoprotective action by reducing toxicity via its ferroxidase activity. We investigated the role of macrophage H-ferritin in obesity and diabetes.
Methods
Conditional macrophage-specific H-ferritin (Fth, also known as Fth1) knockout (LysM-Cre Fth KO) mice were used and divided into four groups: wild-type (WT) and LysM-Cre Fth KO mice with normal diet (ND), and WT and LysM-Cre Fth KO mice with high-fat diet (HFD). These mice were analysed for characteristics of obesity and diabetes, tissue iron content, inflammation, oxidative stress, insulin sensitivity and metabolic measurements. RAW264.7 macrophage cells were used for in vitro experiments.
Results
Iron concentration reduced, and mRNA expression of ferroportin increased, in macrophages from LysM-Cre Fth KO mice. HFD-induced obesity was lower in LysM-Cre Fth KO mice than in WT mice at 12 weeks (body weight: KO 34.6 ± 5.6 g vs WT 40.1 ± 5.2 g). mRNA expression of inflammatory cytokines and infiltrated macrophages and oxidative stress increased in the adipose tissue of HFD-fed WT mice, but was not elevated in HFD-fed LysM-Cre Fth KO mice. However, WT mice fed an HFD had elevated iron concentration in adipose tissue and spleen, which was not observed in LysM-Cre Fth KO mice fed an HFD (adipose tissue [μmol Fe/g protein]: KO 1496 ± 479 vs WT 2316 ± 866; spleen [μmol Fe/g protein]: KO 218 ± 54 vs WT 334 ± 83). Moreover, HFD administration impaired both glucose tolerance and insulin sensitivity in WT mice, which was ameliorated in LysM-Cre Fth KO mice. In addition, energy expenditure, mRNA expression of thermogenic genes, and body temperature were higher in KO mice with HFD than WT mice with HFD. In vitro experiments showed that iron content was reduced, and lipopolysaccharide-induced Tnf-α (also known as Tnf) mRNA upregulation was inhibited in a macrophage cell line transfected with Fth siRNA.
Conclusions/interpretation
Deletion of macrophage H-ferritin suppresses the inflammatory response by reducing intracellular iron levels, resulting in the prevention of HFD-induced obesity and diabetes. The findings from this study highlight macrophage iron levels as a potential therapeutic target for obesity and diabetes.
Similar content being viewed by others
Introduction
Iron is an essential micromineral for all living beings. However, an excessive amount of iron induces oxidative stress by catalysing toxic hydroxy-radical production via the Fenton reaction. In hereditary iron overload disorders, cardiomyopathy, hepatic injury and diabetes are caused by oxidative stress via ectopic tissue accumulation of excess iron [1]. Increased body iron content can be related to many diseases, including liver disease [2, 3], obesity [4], diabetes [5], cardiovascular disease [6, 7] and kidney disease [8]. Therefore, iron reduction could be an effective strategy for ameliorating the pathological conditions in such diseases, as shown by both clinical [9, 10] and experimental studies [11,12,13,14]. Whole body iron reduction causes iron-deficient anaemia; therefore, more specific iron reduction is an important strategy to avoid iron deficiency.
In terms of the dynamics of iron metabolism, iron is mostly recycled in the human body, since daily iron intake and excretion are only 1–1.5 mg each. Body iron is mostly located in erythrocytes (>70%) as haemoglobin. Macrophages phagocytise senescent erythrocytes and release iron obtained from haemoglobin into circulation, where it binds to plasma transferrin [15]. Thus, macrophages are central regulators of body iron homeostasis through the recycling of iron.
Macrophages undergo polarisation to form either the proinflammatory phenotype (M1: classically activated) or the anti-inflammatory phenotype (M2: alternatively activated) [16]. These two phenotypes are characterised by divergent expression of iron-related proteins and iron content [17, 18]. M1 macrophages have increased iron content through the expression of high levels of the iron-storage protein, H-ferritin (ferritin heavy chain; FTH) and low levels of the iron export protein ferroportin (FPN). In contrast, M2 macrophages have low iron content expression with low levels of H-ferritin and high levels of FPN. Differences in polarisation between M1 and M2 macrophages may involve intracellular iron content, affecting macrophage function, especially in the aspect of proinflammatory change [19]. We found that FTH protein expression colocalises with the increase in infiltrated macrophages in the adipose tissue of obese KKAy mice [11]. Additionally, increased iron content enhances the lipopolysaccharide (LPS)-induced inflammatory cytokine production in hepatic macrophages [20], and an iron chelator (deferoxamine) suppresses cytokine production in mouse bone marrow macrophages [21]. We hypothesised that the coordination of ferritin and intracellular iron is a determining factor in the polarisation of macrophages to the inflammatory phenotype.
In this study, we aimed to explore the role of macrophage FTH in obesity and diabetes induced by high-fat diet using macrophage-specific Fth (also known as Fth1) knockout mice.
Methods
Animal preparation and procedures
Floxed Fth mice (B6.129-Fth1tm1.1Lck) (C57BL/6 J background) were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Lysozyme M (LysM)-Cre mice (B6.129P2-Lyz2tm1(cre)Ifo) (C57BL/6J background) were provided by K-i Aihara (Tokushima University). This cross-generated mouse carries both the cre gene and the heterozygous floxed Fth gene (LysM-Cre Fthfl/+). These mice were further mated with floxed Fth mice to generate LysM-Cre Fth knockout (KO) mice. Floxed Fth littermate mice without the LysM-Cre gene were used as control wild-type (WT) mice. The male mice were randomly divided into the following four groups at 6 weeks of age: WT mice fed with control (normal) diet (ND; AIN-93 M, Oriental Yeast Co., Tokyo, Japan); LysM-Cre Fth KO mice fed with ND; WT mice fed with high-fat diet (HFD; HFD-60, Oriental Yeast Co.); and LysM-Cre Fth KO mice fed with HFD. The mice were maintained with ad libitum access to water and the corresponding diet. Twelve weeks later, the mice were euthanised by intraperitoneally injecting an overdose of anaesthesia, and tissues were removed and stored at −80°C until further use. All experimental procedures for mice were performed in accordance with the guidelines of the Animal Research Committee of Tokushima University Graduate School, and the protocol was approved by the Institutional Review Board of Tokushima University Graduate School for animal protection (Permit Number: T28–49).
Peritoneal macrophage isolation
After anaesthesia, mice were intraperitoneally injected with 10 ml sterilised PBS. The abdomen was gently massaged for 5 min, and then PBS was recovered. Collected intraperitoneal PBS was centrifuged at 1.4 g, incubated with erythrocyte lysis buffer for 5 min, and washed and re-centrifuged with fresh PBS twice.
Extraction of tissues after insulin stimulation
After a 24 h fasting, mice under anaesthesia were injected with 1 U/kg insulin through the inferior vena cava. After 3 min, epididymal fat, liver and gastrocnemius muscle were immediately removed and used for analysis.
Cell culture and small interfering RNA transfection
RAW264.7 mouse macrophage cells were purchased from DS Pharma Biomedical Co. (Osaka, Japan), and were maintained and sub-cultured in DMEM containing 10% FBS, according to the culture protocol. Small interfering RNA (siRNA) targeting mouse Fth and a non-targeting siRNA control sequence were purchased from Dharmacon (Horizon Discovery, Cambridge, UK). Transfection of siRNA was performed as described previously [22]. Cells were used for further experiments after 48 h of transfection and then stimulated with 100 ng/ml LPS (FUJIFILM Wako Pure Chemical Corporation, Osaka, Japan) for 2 h. The cells were confirmed not to be contaminated with mycoplasma.
RNA extraction and mRNA expression analysis
The methods used for RNA extraction, cDNA synthesis, and quantitative RT-PCR have been previously described [11]. Briefly, the tissues or cells were homogenised in RNAiso reagent (Takara Bio, Otsu, Japan). RNA extraction and cDNA synthesis were performed according to the manufacturer’s instructions (PrimeScript RT reagent kit with gDNA Eraser [Perfect Real Time], Takara Bio). Quantitative RT-PCR was performed using the CFX Connect Real-Time PCR Detection System (Bio-Rad Laboratories, Hercules, CA, USA) with SYBR Green (THUNDERBIRD SYBR qPCR Mix, TOYOBO Co., Osaka, Japan). The mRNA expression levels were normalised using 36B4 (also known as Rplp0) expression, and the values were compared with the control group in terms of relative fold change. The primer sets used are shown in Table 1.
Protein extraction and western blot analysis
Protein preparation and western blotting were performed as previously described in detail [11]. Tissue or cell samples were homogenised or sonicated in a protein lysis buffer containing proteinase inhibitors and a phosphatase inhibitor. The extracted proteins were boiled for 5 min in Laemmli sample buffer and used for western blotting. The visualised immunoreactive protein bands were semi-quantified by densitometric analysis using Image J software (version 1.38, NIH, Bethesda, MD, USA). We used Can Get Signal Solution 1 (TOYOBO Co.) as dilution buffer for primary antibodies, and 0.5% skimmed milk in PBS-T as dilution buffer for secondary antibodies. The following commercially available antibodies were used: anti-FTH, anti-ferritin light chain (FTL), anti-p22phox (Santa Cruz Biotechnology, Dallas, TX, USA), anti-phospho-stress-activated protein kinase (SAPK)/c-Jun N-terminal kinase (JNK) (Thr183/Tyr185), anti-total SAPK/JNK, anti-phospho-p44/42 mitogen-activated protein kinase (extracellular signal-regulated kinase 1/2 [ERK1/2]), anti-total p44/42 MAPK (ERK1/2), anti-phospho-Akt, anti-total Akt, anti-phospho-insulin receptor β (IRβ), anti-total IRβ (Cell Signaling Technology, Danvers, MA, USA), and anti-α-tubulin (protein loading control; Merck, Darmstadt, Germany). Anti-rabbit IgG, HRP-linked Antibody (Cell Signaling Technology [7074]), goat anti-mouse IgG-HRP-linked antibody (Santa Cruz Biotechnology [sc-2005]), and donkey anti-goat IgG-HRP-linked antibody (Santa Cruz Biotechnology [sc-2020]) were used for secondary antibodies. Details of dilutions used for antibodies are available in Table 2.
Histological analysis of adipocyte size
Epididymal fat tissue was fixed in 4% paraformaldehyde. After defatting and paraffin-embedding, the samples were cut into 3 μm thick sections and stained with haematoxylin–eosin. Adipocyte size was determined by ten random fields in the sections for each mouse [11].
Haematological analysis and blood chemistry
Whole blood cell counts were performed by Shikoku Chuken (Kagawa, Japan). Blood glucose and insulin levels were measured by using an ACCU-CHEK Aviva Kit (Roche Diagnostics, Basel, Switzerland) and a Mouse Insulin ELISA Kit (Morinaga Institute of Biological Science, Yokohama, Japan), respectively [11]. Plasma levels of TNF-α and adiponectin were determined using commercial ELISA kits (Quantikine ELISA Kit, R&D Systems, Minneapolis, MN, USA).
Glucose tolerance test
After fasting for 24 h, mice were intraperitoneally injected with 20% glucose solution (2.0 g/kg body weight). Blood was obtained from a tail vein at scheduled time points (0, 30, 60 and 120 min), and blood glucose levels were measured [11].
Insulin tolerance test
After a 4 h fast, the mice were subjected to an insulin tolerance test. They were injected intraperitoneally with insulin (0.75 U/kg body weight; Humulin R; Eli Lilly, Indianapolis, IN, USA). Blood glucose levels were measured at scheduled times (0, 15, 30, 60 and 120 min) [11].
Immunohistochemistry of macrophages in adipose tissues
Immunohistochemical staining of F4/80 (MCA497GA, Bio-Rad Laboratories, Tokyo, Japan) was performed as described previously [11]. To evaluate macrophage infiltration, ten microscopic fields were randomly selected and F4/80-positive cells were counted.
Detection of oxidative stress in adipose tissue
Oxidative stress was evaluated by anti-4-hydroxynonenal (HNE) staining (MHN-100P, Japan Institute for the Control of Aging (JaICA), Nikken SEIL Co., Shizuoka, Japan). In brief, paraffin sections were deparaffinised and rehydrated, and then boiled with antigen retrieval 10 mmol/l citrate buffer for 10 min and cooled for 20 min. After blocking, sections were incubated with 4-HNE antibody (1:50) at 4°C overnight. Antibody distribution was visualised using immunofluorescence (Alexafluor; Life Technologies, Tokyo, Japan). Sections incubated without primary antibody were used as negative controls.
Measurement of iron content
Tissue iron content was measured using an iron assay kit (Metallo assay, Metallogenics, Chiba, Japan) [12]. Iron concentration was corrected using protein concentration and expressed as μmol Fe per g protein concentration.
Metabolic measurement and body temperature
ARCO-2000 (ARCO System, Chiba, Japan) was used to measure \( \dot{V}{\mathrm{O}}_2 \) and RQ. Mice were placed in ACTIMO-100 N (SHINFACTORY Co., Fukuoka, Japan) with free access to food and water, allowing them to acclimatise in individual metabolic cages for 72 h before any measurements. The data were acquired at 12 h intervals for 24 h. A rectal probe (BP98A Softron Corp., Tokyo, Japan) measured the body temperature of mice.
Statistical analysis
In vivo studies were carried out with at least three independent experiments in each group and sample replication of in vivo data was obtained from individual mice. In vitro studies were done at least twice in independent experiments. Blinding to group assignment and outcome assessment were not carried out in these studies. There were no criteria for exclusion of any data, and no results were intentionally removed. Data are presented as mean ± SD. An unpaired, two-tailed, Student’s t test was used for comparison between the two groups. For comparison between more than two groups, the statistical significance of each difference was evaluated using a post hoc test (either Dunnett’s method or Tukey–Kramer’s method). Statistical significance was set at p< 0.05.
Results
Characteristics of LysM-Cre Fth KO mice and WT mice
First, we examined the Fth deletion in macrophages and other tissues. As shown in Fig. 1a, Fth mRNA was deleted in peritoneal macrophages and was reduced by around 25% in liver samples. There was no difference detected in Fth mRNA expression in the heart, spleen, kidney, adipose tissue and skeletal muscles between WT and LysM-Cre Fth KO mice. In terms of ferritin protein, FTH protein expression was reduced in macrophages and spleen, but not in the liver of KO mice, and there was no difference in FTL protein expression in macrophages, liver or spleen between WT and KO mice (Fig. 1b–d).
Iron concentration and iron-related gene expression in macrophages
In peritoneal macrophages, the iron concentration was lower in LysM-Cre Fth KO mice than in WT mice (Fig. 1e). Fpn (also known as Slc40a1) and Homx1 mRNA expression increased, whereas Tfr (also known as Tfrc) mRNA expression showed a decrease in macrophages in KO mice (Fig. 1f–h). These results suggest that the Fth gene deletion leads to reduced intracellular iron concentration through a decrease in iron import and an increase in iron export in macrophages.
Effect of macrophage Fth deletion on body weight and adipose tissues
Next, we tested the role of the macrophage Fth gene on HFD-induced obesity and diabetes. No difference was seen in body weight gained during the experimental course between WT mice and LysM-Cre Fth KO mice. The body weight of WT mice fed an HFD increased after 2 weeks, whereas this increase was suppressed in KO mice at 12 weeks (body weight: KO 34.6 ± 5.6 g vs WT 40.1 ± 5.2 g) (Fig. 2a,b). There was no difference in the daily energy intake between WT mice and KO mice in the HFD-fed group (Fig. 2c). The HFD-induced increase in weight of adipose tissue was attenuated in KO mice compared with WT mice (Fig. 2d–g). In histological analysis, HFD feeding resulted in enlarged adipocyte size in epididymal fat, and this increase was smaller in KO mice than in WT mice (Fig. 2h,i). The distribution of adipocyte size indicated that LysM-Cre Fth KO mice fed with HFD increased the proportion of small-sized adipocytes and decreased the proportion of large-sized adipocytes compared with WT mice fed with HFD (Fig. 2j). Additionally, erythrocytes, haemoglobin and haematocrit were elevated in HFD-fed mice, and there was no difference in these variables between WT mice and LysM-Cre Fth KO mice regardless of ND or HFD (Table 3).
Macrophage infiltration and inflammatory cytokine expression in adipose tissue
As shown in Fig. 3a and b, the number of F4/80-positive cells was increased in epididymal fat of HFD-fed WT mice, and this was significantly inhibited in HFD-fed KO mice. Similar to the results of immunohistochemical analysis, mRNA expression of F4/80 (also known as Adgre1) and Cd68 was increased in epididymal fat of HFD-fed WT mice, and they were significantly inhibited in HFD-fed KO mice (Fig. 3c,d). The mRNA expression of inflammatory cytokines such as Tnf-α (also known as Tnf), Mcp-1 (also known as Ccl2), Il-1ß (also known as Il1b) and Il-6, were upregulated in epididymal fat of WT mice with HFD, but were diminished in KO mice with HFD (Fig. 3f–i). Adiponectin (Adipoq) mRNA expression was reduced, and leptin (Lep) mRNA expression was increased in the fat of HFD-fed WT mice, while these changes were ameliorated in HFD-fed KO mice (Fig. 3j,k). Additionally, mRNA expression of Cd11c (also known as Itgax), a surface marker of M1-like cells, was elevated in HFD-fed WT mice, but this increase was inhibited in HFD-fed KO mice (Fig. 3e). In plasma, the HFD-induced increase in the TNF-α levels and decrease in adiponectin levels were also ameliorated in KO mice (Fig. 3l,m). These results suggested that macrophage Fth deletion leads to inhibition of HFD-induced inflammation and the disorder of adipocytokines in fat.
Effect of macrophage Fth deletion on MAPK pathway and oxidative stress
JNK and ERK1/2, members of the MAPK family, play an important role in inflammatory gene regulation [23]. Administration of HFD increased the phosphorylated levels of JNK, but not ERK1/2, in the fat of WT mice, and it was suppressed in KO mice (Fig. 4a–c). In adipose tissue, 4-HNE intensity was augmented in WT mice with HFD, and this increase was suppressed in HFD-fed KO mice (Fig. 4d,e). NADPH oxidase is a source of reactive oxygen species, and increase in p22phox protein, an NADPH oxidase subunit with haem protein, was suppressed by iron reduction in adipose tissue from obese mice [11]. In line with this, p22phox was elevated in adipose tissue of HFD-fed WT mice, and this increase was suppressed in adipose tissue of HFD-fed KO mice (Fig. 4f,g). Thus, HFD-induced inflammatory pathway activation and oxidative stress were inhibited in the fat of KO mice.
Iron content in fat, spleen and macrophages
In epididymal fat and spleen, tissue iron content was elevated in HFD-fed WT mice, and this was inhibited in HFD-fed KO mice (adipose tissue [μmol Fe/g protein]: KO 1496 ± 479 vs WT 2316 ± 866; spleen [μmol Fe/g protein]: KO 218 ± 54 vs WT 334 ± 83) (Fig. 4h,i). Iron content in macrophages was lower in KO mice than in WT mice. However, macrophage iron levels did not change by HFD in WT and KO mice (Fig. 4j).
Macrophage Fth deletion on glucose tolerance, insulin sensitivity and insulin signalling pathway
To examine whether macrophage Fth deletion affected glucose tolerance and insulin sensitivity, we subjected mice to IPGTT and IPITT, respectively. There was no difference in blood glucose levels between WT mice and KO mice in ND-fed groups after glucose injection, and the degree of increase in blood glucose level after glucose injection was lower in HFD-fed KO mice than in HFD-fed WT mice (Fig. 5a,b). With IPITT, the reduction in blood glucose levels was more in KO mice than in WT mice in HFD-fed groups, and there was no difference in blood glucose levels between WT mice and KO mice in ND-fed groups after insulin injection (Fig. 5c,d). The phosphorylation of the IRβ–Akt signalling pathway was increased in epididymal fat in ND-fed groups of both WT mice and KO mice after insulin stimulation. Phosphorylated levels of IRβ–Akt signalling after insulin stimulation was diminished in HFD-fed WT mice, and it was ameliorated in the fat of HFD-fed KO mice (Fig. 5e,f). Similarly to fat, the reduced phosphorylation of IRβ–Akt signalling after insulin stimulation was also ameliorated in the liver and skeletal muscle of HFD-fed KO mice (Fig. 6a–f). The mRNA expression of inflammatory cytokines (except for Il-6) was increased in liver and skeletal muscle of HFD-fed WT mice, but this was not seen in those tissues of HFD-fed KO mice (Fig. 6g–n). The fasting plasma glucose level was significantly higher in HFD-fed WT mice than in HFD-fed KO mice. The plasma insulin level was markedly elevated in HFD-fed WT mice; in HFD-fed KO mice, the levels were significantly lower than in HFD-fed KO mice (Table 3). These results suggest that macrophage Fth deletion leads to the improvement in glucose tolerance and insulin resistance both through inhibiting inflammation and maintaining insulin signalling in fat, liver and skeletal muscle in obesity and diabetes.
Effect of macrophage Fth deletion on energy expenditure in mice fed with HFD
We further analysed energy expenditure. \( \dot{V}{\mathrm{O}}_2 \) and energy expenditure were significantly higher in HFD-fed KO mice during the dark phase, while RQ was lower in HFD-fed KO mice compared with HFD-fed WT mice during the dark and total phase (Fig. 7a–c). Additionally, body temperature, as well as the expression of several thermogenic genes (Ucp3, Adrb3, Ppargc1a, Dio2, and Prdm16) in fat, was significantly higher in HFD-fed KO mice compared with HFD-fed WT mice (Fig. 7d–k). These results partly contributed to the decreased body-weight gain in HFD-fed KO mice.
Effect of Fth deletion on LPS-induced inflammation in vitro experiments
We examined the effect of Fth deletion by using RAW264.7 cells derived from mouse peritoneal macrophages. siRNA targeting Fth gene transduction reduced Fth mRNA by approximately 20% and mimicked the phenotype of iron-related genes and iron content in macrophages of LysM-Cre Fth KO mice (Fig. 8a–e). LPS stimulation increased Tnf-α mRNA expression, and it was partly inhibited with Fth siRNA transduction (Fig. 8f).
Discussion
Deletion of the macrophage Fth gene reduced intracellular iron content via changes in iron transporter expression and inhibited the LPS-induced inflammatory response. Macrophage Fth gene KO mice showed diminished HFD-induced inflammatory changes and macrophage infiltration in adipose tissue, contributing to the suppression of obesity and diabetes.
Ferritin is a ubiquitous iron-binding protein and the main form of intracellular iron storage. It is composed of 24-mer heteromultimers of two subtypes: H (FTH) and L (FTL) subunits [24]. FTH has ferroxidase activity (converts Fe2+ to Fe3+). Meanwhile, FTL takes up and maintains iron content by nucleation, although it lacks ferroxidase activity [25,26,27]. Ferritin synthase is mainly regulated by iron at the translational level through both iron-regulatory proteins and iron-responsive elements in the 5′-untranslated regions of Fth and Ftl RNAs [28], and in an iron-independent manner including oxidative stress [29], and in the presence of inflammatory cytokines [30, 31]. In addition to being an iron-storage protein, FTH is normally thought to exert a cytoprotective effect by its antioxidant property, inhibiting the Fenton reaction via ferroxidase activity and the nucleation of free iron ions [26, 27]. Indeed, several studies have shown the protective action of FTH in relation to heart failure (in cardiomyocytes) [32], acute kidney injury (proximal tubules) [33], and ischaemic liver injury (hepatocytes) [34]. In contrast, myeloid (macrophage) Fth gene deficiency alleviates unilateral ureter obstruction-induced renal fibrosis in mice, although the mechanism has not been described in detail [35]. Thus, FTH function might vary depending on cells and tissues, and macrophage Fth deletion exerts a favourable effect on at least renal fibrosis, obesity and diabetes.
Whole-body iron reduction by an iron chelator or an iron-restricted diet has been shown to be beneficial for the inhibition of inflammatory cytokines and oxidative stress in rat and mouse models of obesity and type 2 diabetes [11, 36, 37]. However, these advantages are counterbalanced by iron-deficient anaemia. In this study, macrophage deletion of the Fth gene resulted in reduced iron content, inhibiting the development of HFD-induced obesity and diabetes, inflammatory cytokines, macrophage infiltration and oxidative stress, without giving rise to anaemia. HFD-induced increase of proinflammatory cytokine expression (the M1-like markers: IL-1β, TNF-α, CD68) was diminished in the fat of LysM-Cre Fth KO mice compared with WT mice. Similarly, LPS-induced increase of TNF-α expression was also alleviated in RAW264.7 macrophage cells transfected with Fth siRNA. These findings suggest that macrophage iron plays a pivotal role in the development of obesity and diabetes, and macrophage-specific reduction of iron may be a target for metabolic disorders through the inhibition of the inflammatory response.
It is well established that chronic low-grade inflammation is linked to the development of insulin resistance, obesity and diabetes [38]. An increase of infiltrated macrophages is seen in the visceral fat of obese individuals, and body weight loss leads to a reduction of inflammatory markers and infiltrated macrophages [39, 40]. Diet-induced obesity promotes macrophages to switch to the M1 proinflammatory phenotype from the M2 anti-inflammatory phenotype, contributing to insulin resistance [41]. A shift in the polarisation of adipose tissue macrophages to a proinflammatory phenotype plays a crucial role in the development of obesity and diabetes. Deletion of the Fth gene altered the expression of iron-related genes (decrease of Tfr expression and the increase of Fpn and Homx1 expression) in addition to iron content reduction. Iron metabolism is suggested to involve the regulation of macrophage polarisation. M1-polarised proinflammatory macrophages increase intracellular iron retention with reduction of transferrin receptor (TfR) and FPN and elevation of FTH, while, M2-polarised anti-inflammatory macrophages decrease intracellular iron content with elevation of TfR and FPN and reduction of FTH in vitro [18]. In vivo, in lean adipose tissue, all infiltrated macrophages with low or high iron content are of the M2-like phenotype with greater expression of M2 genes and a reduction in the expression of M1 genes, suggesting the promotion of iron recycling. In obesity, macrophages with high iron levels become more inflammatory and lose the property of iron handling, indicating changes in their polarisation and phenotype [42]. In this study, Fth gene deletion inhibited the proinflammatory response induced by HFD or LPS. However, the change of Tfr expression was in contrast to the M2-like phenotype, and the increase of Fpn and Homx1 expression was agreement with it. However, the effect of FTH overexpression is controversial. FTH overexpression itself increases inducible nitric oxide synthase (iNOS) expression [35], while ferritin induction alleviates the LPS-induced inflammatory response [43]. Further investigation is necessary for clarifying the role of FTH on macrophages in detail.
We showed that LysM-Cre Fth KO mice had higher energy expenditure compared with WT mice following HFD feeding. The body temperature and expression of thermogenic genes in epididymal fat were also higher in HFD-fed KO mice compared with HFD-fed WT mice. White-to-brown fat transition (forming what are known as beige adipocytes) plays a significant role in regulating body weight and protecting against diabetes and obesity through thermogenesis [44]. Therefore, the promotion of browning of white fat may partly involve the alleviation of HFD-induced obesity and diabetes in LysM-Cre Fth KO mice.
In terms of tissue iron content, the HFD induced an increase of tissue iron concentration in epididymal fat and spleen of WT mice, but the increase in iron concentration induced by HFD was suppressed in LysM-Cre Fth KO mice. However, iron content was not increased by HFD in isolated peritoneal macrophages, although macrophage iron content remained lower in KO mice than in WT mice with either ND or HFD. Increased iron content in fat and spleen might be due to the increase in infiltrated macrophages that supply iron to local tissues in mice following HFD. In in vitro models, M1 macrophages display an iron sequestration phenotype with an associated increase in FTH expression. Similar results were obtained in mouse models where the iron content of macrophages of both subtypes was not increased by HFD administration, although the iron content was increased in HFD-induced hypertrophied adipocytes [42]. Thus, there is the discrepancy of M1 macrophage iron content between the in vitro model and in vivo model. In contrast, macrophage iron release is necessary for the repair of skeletal muscle injury through myogenic differentiation. There are no differences in macrophage iron content during muscle injury [45], suggesting that macrophages are the suppliers of iron to local tissue without themselves exhibiting any change in iron content, due to rapid iron release. Further studies are needed to clarify the accurate mechanism.
Body iron content is normally lower in females than males, and several studies have shown the effect of sex hormones on iron metabolism [22, 46]. A limitation of this study is that we only used male mice. Therefore, further study is necessary for clarifying the effect of Fth deletion on macrophages in both sexes.
In conclusion, deletion of the Fth gene in macrophages leads to a reduction of both intracellular iron concentration and inflammatory response, resulting in the prevention of HFD-induced obesity and diabetes. Control of macrophage-specific iron levels is, thus, a potential therapeutic target for regulating chronic inflammation.
Data availability
All data generated or analysed during this study are included in this published article.
Abbreviations
- ERK1/2:
-
Extracellular signal-regulated kinase 1/2
- FPN:
-
Ferroportin
- FTH:
-
Ferritin heavy chain (H-ferritin)
- FTL:
-
Ferritin light chain (L-ferritin)
- HFD:
-
High-fat diet
- HNE:
-
Hydroxynonenal
- IRβ:
-
Insulin receptor β
- JNK:
-
c-Jun N-terminal kinase
- KO:
-
Knockout
- LPS:
-
Lipopolysaccharide
- LysM:
-
Lysozyme M
- MAPK:
-
Mitogen-activated protein kinase
- ND:
-
Normal diet
- SAPK:
-
Stress-activated protein kinase
- siRNA:
-
Small interfering RNA
- TfR:
-
Transferrin receptor
- WT:
-
Wild-type
References
Camaschella C (2005) Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 106(12):3710–3717. https://doi.org/10.1182/blood-2005-05-1857
Ryan Caballes F, Sendi H, Bonkovsky HL (2012) Hepatitis C, porphyria cutanea tarda and liver iron: an update. Liver Int 32(6):880–893. https://doi.org/10.1111/j.1478-3231.2012.02794.x
Dongiovanni P, Fracanzani AL, Fargion S, Valenti L (2011) Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target. J Hepatol 55(4):920–932. https://doi.org/10.1016/j.jhep.2011.05.008
Nikonorov AA, Skalnaya MG, Tinkov AA, Skalny AV (2015) Mutual interaction between iron homeostasis and obesity pathogenesis. J Trace Elem Med Biol 30:207–214. https://doi.org/10.1016/j.jtemb.2014.05.005
Fernandez-Real JM, Manco M (2014) Effects of iron overload on chronic metabolic diseases. Lancet Diabetes Endocrinol 2(6):513–526. https://doi.org/10.1016/S2213-8587(13)70174-8
Kremastinos DT, Farmakis D (2011) Iron overload cardiomyopathy in clinical practice. Circulation 124(20):2253–2263. https://doi.org/10.1161/CIRCULATIONAHA.111.050773
Depalma RG, Hayes VW, Chow BK, Shamayeva G, May PE, Zacharski LR (2010) Ferritin levels, inflammatory biomarkers, and mortality in peripheral arterial disease: a substudy of the Iron (Fe) and Atherosclerosis Study (FeAST) Trial. J Vasc Surg 51(6):1498–1503. https://doi.org/10.1016/j.jvs.2009.12.068
Ribeiro S, Belo L, Reis F, Santos-Silva A (2016) Iron therapy in chronic kidney disease: recent changes, benefits and risks. Blood Rev 30(1):65–72. https://doi.org/10.1016/j.blre.2015.07.006
Nakanishi T, Kuragano T, Nanami M, Otaki Y, Nonoguchi H, Hasuike Y (2010) Importance of ferritin for optimizing anemia therapy in chronic kidney disease. Am J Nephrol 32(5):439–446. https://doi.org/10.1159/000320733
Beaton MD, Chakrabarti S, Levstik M, Speechley M, Marotta P, Adams P (2013) Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 37(7):720–729. https://doi.org/10.1111/apt.12255
Tajima S, Ikeda Y, Sawada K et al (2012) Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab 302(1):E77–E86. https://doi.org/10.1152/ajpendo.00033.2011
Ikeda Y, Enomoto H, Tajima S et al (2013) Dietary iron restriction inhibits progression of diabetic nephropathy in db/db mice. Am J Physiol Ren Physiol 304(7):F1028–F1036. https://doi.org/10.1152/ajprenal.00473.2012
Ikeda Y, Horinouchi Y, Hamano H et al (2017) Dietary iron restriction alleviates renal tubulointerstitial injury induced by protein overload in mice. Sci Rep 7(1):10621. https://doi.org/10.1038/s41598-017-11089-0
Naito Y, Hirotani S, Sawada H, Akahori H, Tsujino T, Masuyama T (2011) Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats. Hypertension 57(3):497–504. https://doi.org/10.1161/HYPERTENSIONAHA.110.159681
Ganz T (2012) Macrophages and systemic iron homeostasis. J Innate Immun 4(5–6):446–453. https://doi.org/10.1159/000336423
Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164(12):6166–6173
Recalcati S, Locati M, Marini A et al (2010) Differential regulation of iron homeostasis during human macrophage polarized activation. Eur J Immunol 40(3):824–835. https://doi.org/10.1002/eji.200939889
Corna G, Campana L, Pignatti E et al (2010) Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 95(11):1814–1822. https://doi.org/10.3324/haematol.2010.023879
Recalcati S, Locati M, Gammella E, Invernizzi P, Cairo G (2012) Iron levels in polarized macrophages: regulation of immunity and autoimmunity. Autoimmun Rev 11(12):883–889. https://doi.org/10.1016/j.autrev.2012.03.003
Tsukamoto H, Lin M, Ohata M, Giulivi C, French SW, Brittenham G (1999) Iron primes hepatic macrophages for NF-κB activation in alcoholic liver injury. Am J Phys 277(6):G1240–G1250. https://doi.org/10.1152/ajpgi.1999.277.6.G1240
Autenrieth IB, Bohn E, Ewald JH, Heesemann J (1995) Deferoxamine B but not deferoxamine G1 inhibits cytokine production in murine bone marrow macrophages. J Infect Dis 172(2):490–496. https://doi.org/10.1093/infdis/172.2.490
Ikeda Y, Tajima S, Izawa-Ishizawa Y et al (2012) Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One 7(7):e40465. https://doi.org/10.1371/journal.pone.0040465
Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC (2006) JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res 82(4):588–596. https://doi.org/10.1016/j.exer.2005.08.019
Harrison PM, Arosio P (1996) The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1275(3):161–203. https://doi.org/10.1016/0005-2728(96)00022-9
Lawson DM, Artymiuk PJ, Yewdall SJ et al (1991) Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature 349(6309):541–544. https://doi.org/10.1038/349541a0
Lawson DM, Treffry A, Artymiuk PJ et al (1989) Identification of the ferroxidase centre in ferritin. FEBS Lett 254(1–2):207–210. https://doi.org/10.1016/0014-5793(89)81040-3
Santambrogio P, Levi S, Cozzi A, Corsi B, Arosio P (1996) Evidence that the specificity of iron incorporation into homopolymers of human ferritin L- and H-chains is conferred by the nucleation and ferroxidase centres. Biochem J 314(Pt 1):139–144
Klausner RD, Harford JB (1989) cis–trans models for post-transcriptional gene regulation. Science 246(4932):870–872. https://doi.org/10.1126/science.2683086
Tsuji Y, Ayaki H, Whitman SP, Morrow CS, Torti SV, Torti FM (2000) Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol Cell Biol 20(16):5818–5827. https://doi.org/10.1128/mcb.20.16.5818-5827.2000
Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM (1991) Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci U S A 88(11):4946–4950. https://doi.org/10.1073/pnas.88.11.4946
Rogers JT (1996) Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 87(6):2525–2537
Omiya S, Hikoso S, Imanishi Y et al (2009) Downregulation of ferritin heavy chain increases labile iron pool, oxidative stress and cell death in cardiomyocytes. J Mol Cell Cardiol 46(1):59–66. https://doi.org/10.1016/j.yjmcc.2008.09.714
Zarjou A, Bolisetty S, Joseph R et al (2013) Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury. J Clin Invest 123(10):4423–4434. https://doi.org/10.1172/JCI67867
Berberat PO, Katori M, Kaczmarek E et al (2003) Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J 17(12):1724–1726. https://doi.org/10.1096/fj.03-0229fje
Bolisetty S, Zarjou A, Hull TD et al (2015) Macrophage and epithelial cell H-ferritin expression regulates renal inflammation. Kidney Int 88(1):95–108. https://doi.org/10.1038/ki.2015.102
Minamiyama Y, Takemura S, Kodai S et al (2010) Iron restriction improves type 2 diabetes mellitus in Otsuka Long–Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 298(6):E1140–E1149. https://doi.org/10.1152/ajpendo.00620.2009
Yan HF, Liu ZY, Guan ZA, Guo C (2018) Deferoxamine ameliorates adipocyte dysfunction by modulating iron metabolism in ob/ob mice. Endocr Connect 7(4):604–616. https://doi.org/10.1530/EC-18-0054
Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25(1):4–7. https://doi.org/10.1016/j.it.2003.10.013
Cancello R, Henegar C, Viguerie N et al (2005) Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54(8):2277–2286. https://doi.org/10.2337/diabetes.54.8.2277
Cancello R, Tordjman J, Poitou C et al (2006) Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 55(6):1554–1561. https://doi.org/10.2337/db06-0133
Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117(1):175–184. https://doi.org/10.1172/JCI29881
Orr JS, Kennedy A, Anderson-Baucum EK et al (2014) Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes 63(2):421–432. https://doi.org/10.2337/db13-0213
Zarjou A, Black LM, McCullough KR et al (2019) Ferritin light chain confers protection against sepsis-induced inflammation and organ injury. Front Immunol 10:131. https://doi.org/10.3389/fimmu.2019.00131
Wu J, Bostrom P, Sparks LM et al (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150(2):366–376. https://doi.org/10.1016/j.cell.2012.05.016
Corna G, Caserta I, Monno A et al (2016) The repair of skeletal muscle requires iron recycling through macrophage ferroportin. J Immunol 197(5):1914–1925. https://doi.org/10.4049/jimmunol.1501417
Guo W, Bachman E, Li M et al (2013) Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 12(2):280–291. https://doi.org/10.1111/acel.12052
Acknowledgements
We appreciate the excellent technical advice by the Support Centre for Advanced Medical Sciences, Institute of Biomedical Sciences, Tokushima University Graduate School. We would like to thank Editage (www.editage.jp) for their help with English language editing.
Funding
This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant (18 K08480 to YI).
Author information
Authors and Affiliations
Contributions
YI conceived the study, designed experiments, acquired and analysed the data, and wrote the manuscript. HW, TS and HH acquired and analysed the data and drafted the manuscript. YH contributed to the analysis and interpretation of the data and reviewed the manuscript. MI, MG, YZ, KTa, YI-I, LM and KI contributed to the analysis and interpretation of the data and assisted in the preparation of the manuscript. K-iA and KTs contributed to analysis and interpretation of the data and critically reviewed the manuscript. TT contributed to interpretation of the data and critically reviewed the manuscript. YI and HW are the guarantors of this work and, as such, had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All the authors approved the final version of this manuscript.
Corresponding author
Ethics declarations
The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ikeda, Y., Watanabe, H., Shiuchi, T. et al. Deletion of H-ferritin in macrophages alleviates obesity and diabetes induced by high-fat diet in mice. Diabetologia 63, 1588–1602 (2020). https://doi.org/10.1007/s00125-020-05153-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-020-05153-0